DalsnaFinance › IPOs › Biohaven Pharmaceutical Holding Co Ltd.

Biohaven Pharmaceutical Holding Co Ltd. IPO

Completed

Biohaven Pharmaceutical Holding Co Ltd. completed its initial public offering on NYSE on May 4, 2017, pricing at $17.00 a share.

Ticker	BHVN
Exchange	NYSE
Status	Completed
Listing date	May 4, 2017
Offering price	$17.00
Shares offered	9,900,000
Total raised	$168M

Company coverage

Biohaven Pharmaceutical Holding Co Ltd. — quote, profile and latest news →

Other recent IPOs

• Gores Holdings XI, Inc. · June 22, 2026
• SpaceX · June 12, 2026
• Avalanche Treasury Corp · June 11, 2026
• JAB Acquisition Corp I · June 9, 2026
• Snow Rothschild Acquisition Corp. · June 8, 2026
• INNIO N.V. · June 4, 2026
• DISCIPLINED GROWTH ACQUISITION Corp · May 26, 2026
• Peace Acquisition Corp. · May 21, 2026

IPO data is compiled from SEC filings. This page is general information, not investment advice.